# Interactions of traumatic brain injury with pre-existing mild epilepsy on thalamocortical dysfunction, sensory processing, and seizures

> **NIH VA I01** · VETERANS HEALTH ADMINISTRATION · 2022 · —

## Abstract

During the recent conflicts in Iraq and Afghanistan, thousands of service personnel suffered mild traumatic
brain injuries (mTBIs), those that do not cause gross anatomical damage or hemorrhage and produce only
brief periods of altered awareness. Although these brain injuries are classified as “mild,” many veterans with
mTBI experience short- and long-term neurological dysfunction including epilepsy and somatosensory (SS)
dysregulation that may underlie pain/headache. We urgently need new mTBI therapies.
 Most previous investigations of mTBI pathophysiology focused on injury effects on the histology, physiology
and cellular biology of neurons in small brain regions near a point of focal injury. However, explosive blasts
impacting widespread brain regions comprise most modern combat mTBIs and thus there is often no single
point of focal injury. Moreover, new data suggest that dysfunction of large-scale brain networks (spatially
separate, but functionally connected brain regions) lead to epilepsy and SS processing disorders. Therefore, it
is critical to determine the effects of mTBI on large scale brain networks and if therapeutically modulating
network physiology (e.g. brain stimulation) reduces seizures and their comorbidities. Previous studies in
nontraumatic patients and animal models demonstrated that abnormal physiology within SS thalamocortical
(ssTC) and somatosensory corticocortical (ssCC) networks are strongly associated with focal and generalized
seizures and SS processing disorders. Therefore, it is likely that mTBI will also alter ssCC and ssTC
physiology to produce epilepsy and SS dysregulation.
 Genetic risk factors likely play an important role in the development of post-mTBI seizures. A family history
of epilepsy increases the risk of post-mTBI epilepsy from 1.5-2.2-fold to 5.8-fold risk and epidemiology studies
suggest that 9.3% mTBI patients have a first degree relative with epilepsy. To develop network-specific
therapies (e.g. neurostimulation), it is necessary to know whether mTBI causes different epileptogenic changes
in ssTC and ssCC networks in genetically susceptible individuals.
 This application will test the overarching hypothesis that mTBI alters the activity and
connectivity of ssCC and ssTC networks to produce post-mTBI seizures and SS dysfunction and that these
changes are greater in subjects with genetic vulnerabilities. This hypothesis will be tested using a top-down
clinically translatable approach to determine the effects of mTBI on 1) seizures/SS function (Aim 1), 2) long-
range ssCC connectivity using high density EEG (HdEEG, Aim2 A/B) and 3) ssTC connectivity by
HdEEG/stereotactic EEG (SEEG, Aim 2C). Importantly, (Aim 3) primary somatosensory cortex (S1) activity will
then be causally manipulated to determine the effects on ssCC/ssTC network connectivity and seizures and to
extend the observations beyond mere correlation and provide a foundation for future studies of network-
specific modulation therapies (e.g...

## Key facts

- **NIH application ID:** 10259923
- **Project number:** 1I01BX005316-01A1
- **Recipient organization:** VETERANS HEALTH ADMINISTRATION
- **Principal Investigator:** MARTIN J GALLAGHER
- **Activity code:** I01 (R01, R21, SBIR, etc.)
- **Funding institute:** VA
- **Fiscal year:** 2022
- **Award amount:** —
- **Award type:** 1
- **Project period:** 2021-10-01 → 2025-09-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10259923

## Citation

> US National Institutes of Health, RePORTER application 10259923, Interactions of traumatic brain injury with pre-existing mild epilepsy on thalamocortical dysfunction, sensory processing, and seizures (1I01BX005316-01A1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10259923. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
